These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34121363)

  • 21. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review.
    Rabkin SW; Tang JKK
    Heart Fail Rev; 2021 Jul; 26(4):799-812. PubMed ID: 32472523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different determinants of exercise capacity in HFpEF compared to HFrEF.
    Batalli A; Ibrahimi P; Bytyçi I; Ahmeti A; Haliti E; Elezi S; Henein MY; Bajraktari G
    Cardiovasc Ultrasound; 2017 Apr; 15(1):12. PubMed ID: 28446199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
    Chandra A; Vaduganathan M; Lewis EF; Claggett BL; Rizkala AR; Wang W; Lefkowitz MP; Shi VC; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV; Solomon SD;
    JACC Heart Fail; 2019 Oct; 7(10):862-874. PubMed ID: 31302043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.
    Sato T; Yoshihisa A; Kanno Y; Suzuki S; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
    Eur J Prev Cardiol; 2017 Dec; 24(18):1979-1987. PubMed ID: 29086584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function.
    Tanaka S; Sanuki Y; Ozumi K; Harada T; Tasaki H
    Heart Vessels; 2018 Aug; 33(8):886-892. PubMed ID: 29392470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The HEART Camp Exercise Intervention Improves Exercise Adherence, Physical Function, and Patient-Reported Outcomes in Adults With Preserved Ejection Fraction Heart Failure.
    Alonso WW; Kupzyk KA; Norman JF; Lundgren SW; Fisher A; Lindsey ML; Keteyian SJ; Pozehl BJ
    J Card Fail; 2022 Mar; 28(3):431-442. PubMed ID: 34534664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction.
    Konishi M; Kagiyama N; Kamiya K; Saito H; Saito K; Ogasahara Y; Maekawa E; Misumi T; Kitai T; Iwata K; Jujo K; Wada H; Kasai T; Nagamatsu H; Ozawa T; Izawa K; Yamamoto S; Aizawa N; Makino A; Oka K; Momomura SI; Matsue Y
    Eur J Prev Cardiol; 2021 Aug; 28(9):1022-1029. PubMed ID: 33624112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
    Bekfani T; Pellicori P; Morris D; Ebner N; Valentova M; Sandek A; Doehner W; Cleland JG; Lainscak M; Schulze PC; Anker SD; von Haehling S
    Clin Res Cardiol; 2019 Feb; 108(2):203-211. PubMed ID: 30051186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction.
    Malik J; Shahid AW; Shah M; Rana G; Kamal A; Naeem H
    J Community Hosp Intern Med Perspect; 2021; 11(5):629-634. PubMed ID: 34567453
    [No Abstract]   [Full Text] [Related]  

  • 35. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life.
    Bekfani T; Pellicori P; Morris DA; Ebner N; Valentova M; Steinbeck L; Wachter R; Elsner S; Sliziuk V; Schefold JC; Sandek A; Doehner W; Cleland JG; Lainscak M; Anker SD; von Haehling S
    Int J Cardiol; 2016 Nov; 222():41-46. PubMed ID: 27454614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany.
    Hashemi D; Blum M; Mende M; Störk S; Angermann CE; Pankuweit S; Tahirovic E; Wachter R; Pieske B; Edelmann F; Düngen HD;
    ESC Heart Fail; 2020 Jun; 7(3):942-952. PubMed ID: 32003157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise-induced pulmonary hypertension in HFpEF and HFrEF: Different pathophysiologic mechanism behind similar functional impairment.
    Pugliese NR; Mazzola M; Madonna R; Gargani L; De Biase N; Dini FL; Taddei S; De Caterina R; Masi S
    Vascul Pharmacol; 2022 Jun; 144():106978. PubMed ID: 35301117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between systolic ejection time and outcomes in heart failure by ejection fraction.
    Patel PA; Ambrosy AP; Phelan M; Alenezi F; Chiswell K; Van Dyke MK; Tomfohr J; Honarpour N; Velazquez EJ
    Eur J Heart Fail; 2020 Jul; 22(7):1174-1182. PubMed ID: 31863532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.
    D'Assante R; Arcopinto M; Rengo G; Salzano A; Walser M; Gambino G; Monti MG; Bencivenga L; Marra AM; Åberg DN; De Vincentiis C; Ballotta A; Bossone E; Isgaard J; Cittadini A
    ESC Heart Fail; 2021 Apr; 8(2):1681-1686. PubMed ID: 33512777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Scherbakov N; Bauer M; Sandek A; Szabó T; Töpper A; Jankowska EA; Springer J; von Haehling S; Anker SD; Lainscak M; Engeli S; Düngen HD; Doehner W
    Eur J Heart Fail; 2015 Oct; 17(10):1015-21. PubMed ID: 26198713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.